Deborah Cosentini Antonella Turla Ornella Carminati Salvatore Grisanti Vittorio Domenico Ferrari Marta Laganà Giovanni Rosti Sandra Sigala Alfredo Berruti
10.3389/fendo.2021.674039
Front Endocrinol (Lausanne)
2021 Apr 22;12:674039.
acc adrenal tumor alkylating drug progesterone treatment
CC BY
https://pubmed.ncbi.nlm.nih.gov/33967965/
Adrenal Cortex Neoplasms / drug therapy Adrenocortical Carcinoma / drug therapy Antineoplastic Combined Chemotherapy Protocols / therapeutic use
Adrenal Cortex Neoplasms / drug therapy Adrenocortical Carcinoma / drug therapy Antineoplastic Combined Chemotherapy Protocols / therapeutic use Case Reports Research Support, Non-U.S. Gov't Adrenal Cortex Neoplasms / pathology Adrenocortical Carcinoma / secondary Adult Cisplatin / administration & dosage Doxorubicin / administration & dosage Etoposide / administration & dosage Female Humans Mitotane / administration & dosage Prognosis Remission Induction Temozolomide / administration & dosage Young Adult Etoposide Mitotane Doxorubicin Cisplatin Temozolomide
PMC8101262
33967965
Case Report: Exceptional Response to Second Line Temozolomide Therapy in a Patient With Metastatic Adrenocortical Carcinoma
2021